BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28927899)

  • 21. Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia.
    Lybol C; Sweep FC; Ottevanger PB; Massuger LF; Thomas CM
    Int J Gynecol Cancer; 2013 Jul; 23(6):1150-6. PubMed ID: 23714707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience.
    Maestá I; Nitecki R; Horowitz NS; Goldstein DP; de Freitas Segalla Moreira M; Elias KM; Berkowitz RS
    Gynecol Oncol; 2018 Jan; 148(1):161-167. PubMed ID: 29092742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole.
    Uberti EM; Diestel MC; Guimarães FE; De Nápoli G; Schmid H
    Gynecol Oncol; 2006 Aug; 102(2):325-32. PubMed ID: 16476471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Chorionic Gonadotropin Regression Curves after Partial or Complete Molar Pregnancy in Flanders: Are They Different from Regression Curves from the Eighties?
    Delattre S; Han S; Moerman P; Billen J; Goffin F; Scharpé K; Vergote I
    Gynecol Obstet Invest; 2018; 83(1):76-82. PubMed ID: 28329740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment.
    Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H
    Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presentation, medical complications and development of gestational trophoblastic neoplasia of hydatidiform mole after intracytoplasmic sperm injection as compared to hydatidiform mole after spontaneous conception - a retrospective cohort study and literature review.
    Braga A; Andrade T; do Carmo Borges de Souza M; Campos V; Freitas F; Maestá I; Sun SY; Pedrotti LG; Bessel M; Junior JA; Filho JR; Elias KM; Horowitz NS; Berkowitz RS
    Gynecol Oncol; 2023 Mar; 170():179-185. PubMed ID: 36706644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia.
    Lertkhachonsuk R; Tantbirojn P; Paiwattananupant K
    J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of High-Dose Vitamin A Treatment in Postmolar Patients with Low and Plateauing Serum Human Chorionic Gonadotropin Levels.
    Uberti EMH; Diaz RKE; Cardoso RB; Braga A
    Rev Bras Ginecol Obstet; 2020 May; 42(5):240-247. PubMed ID: 32483804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postmolar trophoblastic disease in women using hormonal contraception with and without estrogen.
    Eddy GL; Schlaerth JB; Nalick RH; Gaddis O; Nakamura RM; Morrow CP
    Obstet Gynecol; 1983 Dec; 62(6):736-40. PubMed ID: 6633999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. State-of-the-Art Workup and Initial Management of Newly Diagnosed Molar Pregnancy and Postmolar Gestational Trophoblastic Neoplasia.
    Elias KM; Berkowitz RS; Horowitz NS
    J Natl Compr Canc Netw; 2019 Nov; 17(11):1396-1401. PubMed ID: 31693988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia.
    Braga A; Maestá I; Rocha Soares R; Elias KM; Custódio Domingues MA; Barbisan LF; Berkowitz RS
    Am J Obstet Gynecol; 2016 Sep; 215(3):336.e1-336.e12. PubMed ID: 27094961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?
    Braga A; Torres B; Burlá M; Maestá I; Sun SY; Lin L; Madi JM; Uberti E; Viggiano M; Elias KM; Berkowitz RS
    Gynecol Oncol; 2016 Dec; 143(3):558-564. PubMed ID: 27640962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.
    Growdon WB; Wolfberg AJ; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
    J Reprod Med; 2006 Nov; 51(11):871-4. PubMed ID: 17165432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.
    Feltmate CM; Growdon WB; Wolfberg AJ; Goldstein DP; Genest DR; Chinchilla ME; Lieberman ES; Berkowitz RS
    J Reprod Med; 2006 Nov; 51(11):902-6. PubMed ID: 17165438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early prediction of post-molar gestational trophoblastic neoplasia and resistance to methotrexate, based on a single serum human chorionic gonadotropin measurement.
    Hoeijmakers YM; Eysbouts YK; Massuger LFAG; Dandis R; Inthout J; van Trommel NE; Ottevanger PB; Thomas CMG; Sweep FCGJ
    Gynecol Oncol; 2021 Dec; 163(3):531-537. PubMed ID: 34602288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral contraceptives and postmolar trophoblastic disease.
    Berkowitz RS; Goldstein DP; Marean AR; Bernstein M
    Obstet Gynecol; 1981 Oct; 58(4):474-7. PubMed ID: 6269038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manual Compared With Electric Vacuum Aspiration for Treatment of Molar Pregnancy.
    Padrón L; Rezende Filho J; Amim Junior J; Sun SY; Charry RC; Maestá I; Elias KM; Horowitz N; Braga A; Berkowitz RS
    Obstet Gynecol; 2018 Apr; 131(4):652-659. PubMed ID: 29528932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
    Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
    Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a routine second curettage for hydatidiform mole: a cohort study.
    Yamamoto E; Nishino K; Niimi K; Watanabe E; Oda Y; Ino K; Kikkawa F
    Int J Clin Oncol; 2020 Jun; 25(6):1178-1186. PubMed ID: 32144509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.